Journal of Liver

Total mesopancreas excision for pancreatic head cancer: Analysis of 120 cases

4^th International Conference on Hepatology

April 27-28, 2017 Dubai, UAE

Yingbin Liu

Xinhua Hospital- Shanghai Jiao Tong University School of Medicine, China

Keynote: J Liver

Abstract:

Objective: To evaluate the feasibility and safety of total mesopancreas excision (TMpE) in the treatment of pancreatic head cancer. Methods: The clinical and pathological data of 120 patients with pancreatic head cancer who had undergone TMpE in our center from May 2010 to January 2014 were retrospectively analyzed. Results: The mean operative time was 275.0±50.2 min and the average intra-operative blood loss was 390.0±160.5 mL. Postoperative complications were reported in 45 patients, while no peri-operative death was noted. The specimen margins were measured in three dimensions, and 86 patients (71.6%) achieved R0 resection. Conclusions: TMpE is safe and feasible for pancreatic head cancer and is particularly helpful to increase the R0 resection rate.

Biography :

Yingbin Liu has his expertise in improving the prognosis of hepato-biliary-pancreatic diseases. He is Vice President of Xinhua Hospital, Dean of Institute of Biliary Tract Disease Research, and Chief of General Surgery Department, Xinhua Hospital, Shanghai Jiaotong University.

Email: laoniulyb@163.com